Capital International, Inc. Adagene Inc. Transaction History
Capital International, Inc.
- $7.23 Billion
- Q2 2024
Shares
4 transactions
Others Institutions Holding ADAG
# of Institutions
14Shares Held
9.89MCall Options Held
0Put Options Held
0-
Wu Xi App Tec Co., Ltd. Shanghai, F43.98MShares$8.8 Million52.26% of portfolio
-
Fil LTD Hamilton, D03.83MShares$8.46 Million0.01% of portfolio
-
Sc China Holding LTD N/A, K31.34MShares$2.97 Million0.15% of portfolio
-
General Atlantic LLC New York, NY264KShares$583,4400.03% of portfolio
-
Barclays PLC London, X0187KShares$413,0550.0% of portfolio
About Adagene Inc.
- Ticker ADAG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,423,200
- Market Cap $96M
- Description
- Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...